Clustering data with hclust algorithm for (Study ST003282)

(Analysis AN005377)
MetaboliteStructureF1F2F3F4F5F6F7F8F9F10F11F12F13F14F15F16F17F18F19F20F21F22F23F24F25F26F27F28
4-imidazoleacetateME8614150.290.170.080.160.100.400.290.073.110.150.610.350.320.130.340.290.5715.621.920.730.210.140.210.120.130.360.300.06
hexanoateME8614231.190.330.660.240.460.280.690.281.850.801.300.470.540.530.260.221.319.720.332.010.500.430.421.651.150.980.400.30
azelateME8614180.240.290.260.280.321.810.260.258.100.250.260.280.367.961.790.260.710.370.540.250.270.290.380.250.260.260.490.23
n-acetylprolineME8614341.900.280.632.040.340.329.320.910.300.290.320.310.320.622.250.691.780.330.080.310.410.430.980.282.630.240.580.25
n-acetylasparagineME8614320.060.760.180.170.888.570.162.730.242.070.101.500.331.811.640.340.740.160.210.260.05NA0.190.150.051.000.19NA
methylmalonateME8614280.240.161.380.530.380.600.300.630.356.380.300.320.652.870.291.133.360.670.550.250.601.222.020.130.440.640.770.57
succinateME8614400.300.061.160.310.160.450.240.580.175.940.200.300.512.960.130.903.910.390.670.150.721.262.180.020.450.490.630.75
2-oxobutyric acidME8614130.612.750.650.480.470.380.480.630.633.100.620.541.884.030.540.530.420.720.620.611.100.520.540.481.160.772.250.46
malonateME8614270.010.07NANA0.020.51NANANA3.98NANA0.025.940.03NA0.401.510.01NA0.340.130.46NA0.010.060.190.11
pantothenateME8614351.500.183.891.860.240.140.160.200.090.050.320.520.160.900.283.100.790.180.100.300.083.601.740.570.520.100.152.32
fumarateME8614210.600.430.760.930.762.470.530.770.160.182.893.750.202.640.820.441.150.200.100.380.130.170.150.201.340.390.371.24
pyruvateME8614372.250.180.220.460.751.070.920.440.950.290.636.680.172.170.640.061.460.510.470.581.060.200.060.822.360.060.960.96
n-acetylalanineME8614311.730.070.565.030.980.981.752.930.951.600.300.630.581.090.190.040.050.020.480.270.321.310.250.112.060.380.560.26
n-acetylglycineME8614332.750.200.190.270.740.250.400.801.061.280.701.320.210.652.590.580.201.580.220.190.410.501.680.700.592.040.344.29
levulinic acidME8614250.77NANA1.61NA1.480.190.970.010.580.441.49NA0.21NANA0.54NANA2.110.620.340.272.27NANA0.831.52
akgME8614170.720.810.151.040.350.580.260.440.720.211.412.480.170.300.240.370.221.112.143.471.250.200.262.752.020.200.210.19
malateME8614261.280.920.022.150.031.411.56NA1.760.261.181.480.000.020.250.000.571.741.421.872.480.47NA1.530.410.000.000.22
adipic acidME8614160.560.690.810.484.740.890.480.750.391.540.470.501.981.190.390.610.681.481.090.560.671.532.200.481.040.480.880.43
(+/-)-3-methyl-2-oxovaleric acid sodium saltME8614122.381.140.331.191.580.321.620.351.842.290.540.650.311.081.220.631.200.761.940.300.190.050.190.670.281.011.460.90
butyric acidME8614201.881.510.610.150.360.920.591.381.001.371.091.860.161.780.731.000.640.720.610.400.590.470.720.290.380.951.670.95
n-acetyl-isoleucineME8614300.740.660.520.581.191.030.502.220.421.080.101.450.851.070.852.921.690.810.400.640.790.340.590.422.751.180.800.76
sebacic acidME8614381.530.560.441.351.720.570.461.160.870.530.940.870.630.501.112.561.550.890.861.610.480.490.380.690.590.711.771.18
benzoateME8614190.831.281.201.541.121.410.991.581.131.090.491.040.670.200.391.301.281.330.880.941.120.581.270.611.080.41NA0.99
pyroglutamateME8614361.511.052.091.560.710.430.610.461.070.431.460.360.880.190.800.741.541.181.230.810.670.920.970.931.381.501.411.00
glutarateME8614221.77NA1.240.730.571.491.800.050.311.261.100.372.781.260.31NA0.600.231.130.150.571.311.400.162.320.520.920.76
ureidopropionateME8614410.370.421.610.380.991.960.370.380.380.391.200.363.091.230.830.630.401.072.391.530.371.501.750.420.961.511.120.38
suberateME8614390.050.150.60NA1.271.13NA0.60NANA0.08NA0.950.631.06NA0.850.200.21NANA2.153.10NA0.411.901.300.49
lactateME8614240.910.341.01NA0.682.370.97NA1.291.711.170.13NA0.080.15NA0.70NA0.711.350.971.131.06NA0.171.001.85NA
n-acetyl-beta-alanineME861429NANA0.51NA0.321.160.43NANA0.13NANA0.86NA0.600.19NANA1.392.490.411.730.50NA0.260.920.820.70

Factors:

F1Treatment:ctrl_1hr | Sample source:Bovine aortic endothelial cells
F2Treatment:ctrl_24hr | Sample source:Bovine aortic endothelial cells
F3Treatment:ctrl_4hr | Sample source:Bovine aortic endothelial cells
F4Treatment:ctrl_8hr | Sample source:Bovine aortic endothelial cells
F5Treatment:gln_1hr | Sample source:Bovine aortic endothelial cells
F6Treatment:gln_24hr | Sample source:Bovine aortic endothelial cells
F7Treatment:gln_4hr | Sample source:Bovine aortic endothelial cells
F8Treatment:gln_8hr | Sample source:Bovine aortic endothelial cells
F9Treatment:gln_gluc_1hr | Sample source:Bovine aortic endothelial cells
F10Treatment:gln_gluc_24hr | Sample source:Bovine aortic endothelial cells
F11Treatment:gln_gluc_4hr | Sample source:Bovine aortic endothelial cells
F12Treatment:gln_gluc_8hr | Sample source:Bovine aortic endothelial cells
F13Treatment:gln_pyr_1hr | Sample source:Bovine aortic endothelial cells
F14Treatment:gln_pyr_24hr | Sample source:Bovine aortic endothelial cells
F15Treatment:gln_pyr_4hr | Sample source:Bovine aortic endothelial cells
F16Treatment:gln_pyr_8hr | Sample source:Bovine aortic endothelial cells
F17Treatment:gluc_1hr | Sample source:Bovine aortic endothelial cells
F18Treatment:gluc_24hr | Sample source:Bovine aortic endothelial cells
F19Treatment:gluc_4hr | Sample source:Bovine aortic endothelial cells
F20Treatment:gluc_8hr | Sample source:Bovine aortic endothelial cells
F21Treatment:gluc_pyr_1hr | Sample source:Bovine aortic endothelial cells
F22Treatment:gluc_pyr_24hr | Sample source:Bovine aortic endothelial cells
F23Treatment:gluc_pyr_4hr | Sample source:Bovine aortic endothelial cells
F24Treatment:gluc_pyr_8hr | Sample source:Bovine aortic endothelial cells
F25Treatment:pyr_1hr | Sample source:Bovine aortic endothelial cells
F26Treatment:pyr_24hr | Sample source:Bovine aortic endothelial cells
F27Treatment:pyr_4hr | Sample source:Bovine aortic endothelial cells
F28Treatment:pyr_8hr | Sample source:Bovine aortic endothelial cells
Data matrix
  logo